More of a cautionary winter’s tale than a midsummer night’s dream, an Indiana farmer facing legal action from a certain biotech and chemical multinational behemoth
In late March, The United States Supreme Court ordered the U.S Court of Appeal for the Federal Circuit to reconsider Myriad Genetics’ existing patent on